The Latest Breaking News from Johns Hopkins University

ANAHEIM, Calif. — California is scaling back how often it publicly reports coronavirus case, death, testing and other numbers on the health department website, and some counties are following suit — to mixed reaction from public health experts.

This week, a Senate-passed bill to create a state fund to provide psychedelics to military veterans was taken up by a Maryland House of Delegates. The goal of the fund is to provide “cost-free” access to substances such as psilocybin, MDMA, and ketamine to treat post-traumatic stress disorder (PTSD) and traumatic…

It includes commentary by housing policy specialist Emily Hamilton (Mercatus Center), and economist Filipe Campante (Johns Hopkins University).

Late Thursday, Mydecine Innovations Group (OTC:MYCOF) reported financial results for the fiscal year ended December 31, 2021. 2021 Financial Results Net loss attributable to common stockholders was $28.9 million, which consisted of a $5.3 million loss from discontinued operations, for 2021, or a basic and diluted loss per share attributable…

Light from Earendel has travelled for an estimated 12.9bn years to reach Earth

Scientists were ‘surprised’ to find a star that is much farther than the previous record-holder, which was nine billion light years away.

For Spencer Shattuck, it started with the Montblanc pens that his father would bring home from board meetings.

BALTIMORE -- In a high-tech lab on Johns Hopkins University’s Homewood campus in Baltimore, engineers have been building a robot that may be able to stitch back together the broken vessels in your belly and at some point maybe your brain, no doctor needed.

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received full approval in both Utah chambers, standing out from among dozens of measures currently circulating in legislatures across several U.S. states. Psychedelic science also took an important step forward with the publication…

LOVE Pharma Co. (CSE:LUV) (FSE:G1Q0) updated details on the proposed Microdoz Therapy acquisition, whereby Microdoz has engaged exclusively with researchers at Johns Hopkins University, to conduct a landmark study into the potential of psilocybin assisted treatment of cannabis use disorder.

A new review study by Johns Hopkins University researchers is shedding light on the long-term effects of psilocybin in the treatment of major depression. In a new study, 58% of participants with major depressive disorder were in remission after one year of doing two sessions with psilocybin.